Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5938
-2.5 %
$ 152 M
Market Cap
-3.49
P/E
ADAP - OTHER CURRENT LIABILITIES
Other Current Liabilities ADAP - Adaptimmune Therapeutics plc
28.9 M
LAST VALUE
2.36%
2 YEAR CAGR
7.27%
5 YEAR CAGR
-5.43%
10 YEAR CAGR